Compare DexCom, Inc. (DXCM) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Suncor Energy Inc. — how do they compare? DexCom, Inc. trades at $77.6 (market cap $28.06B), while Suncor Energy Inc. trades at $61.3 (market cap $70.89B). The key difference: Suncor Energy Inc. is far larger — about 2.5× DexCom, Inc.'s market cap, and Suncor Energy Inc. pays a 2.78% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | SU | |
|---|---|---|
Market Cap | $28.06B | $70.89B |
Sector | Health | Energy |
52-Week High | $89.53 | $69.73 |
52-Week Low | $54.84 | $38.17 |
Enterprise Value | $27.03B | $79.02B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Suncor Energy (SU) trades at $61.04, down 0.38% on the day, with a bullish technical signal supported by moving averages. The company maintains solid fundamentals with a P/E of 16.37, net income margin of 11.62%, and consistent positive cash flow from operations ($12.78B in 2025). Recent quarterly earnings show a mixed pattern, beating expectations in Q3 and Q4 2025 but missing in Q1 2026, while Q2 2026 results are pending. The stock offers a dividend yield with a recent $0.60 per share payment announced for June 2026.
SU presents a compelling value opportunity with attractive valuation metrics (EV/EBITDA 6.91) and strong analyst support (74% buy ratings). Key opportunities include operational improvements, record production levels, and shareholder returns through dividends. Primary risks involve commodity price volatility, recent operational incidents like the Sarnia refinery fire, and broader energy sector headwinds from potential oil price declines and recession concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
